26.02.11

Ceník přístrojů od kompletátorů - porovnejte

MEDICAL TRIBUNE CZ > Ceník přístrojů od kompletátorů - porovnejte


...Senátorka MUDr. Alena Dernerová píše pro měsíčník Občan v síti analýzu kontrolní činnosti při čerpání evropských peněz na nákup zdravotnických přístrojů. V článku najdete zajímavou tabulku porovnání běžných cen přístrojů s cenami, které "vysoutěžily" kompletátorské firmy nejen v Krajské zdravotní, ale i ve státem řízených nemocnicích...

Prostate Cancer Survival Unhurt by Intermittent Androgen Suppression - OncologySTAT

Prostate Cancer Survival Unhurt by Intermittent Androgen Suppression - OncologySTAT

...Continuous, lifelong androgen deprivation using an LHRH analogue has been the standard of care for men with PSA failure after radical prostate radiotherapy for the past 20 years. PR7 is a large, well-conducted phase III trial that compares this approach with intermittent therapy, using the LHRH analogue for 8 months at a time and then withholding further therapy until the PSA rises above 10 ng/mL. The trial provides good quality evidence that intermittent therapy is as effective as continuous treatment, and that in using the intermittent approach, patients will spend the majority of time off treatment. Given that intermittent therapy will be considerably cheaper than continuous treatment, and less morbid, it should be regarded as the new standard of care for men with PSA failure after radiotherapy......

06.02.11

Dexpanthenol

Dutina ústní


Rp.


Dexpanthenoli 5,0
Natrii benzoatis 0,15
Acidi citrici monohydr. 0,11
Aquae purificatae ad 100,0
M. f. sol.


užití


  • 1–3× denně nanášet na postižená místa
  • Výplachy úst a vlhké krytí: roztok se před použitím naředí stejným dílem čerstvě převařené vody
  • Výplachy úst: 3–4× denně asi 5–10 ml takto naředěného roztoku se 3 minuty ponechá v ústech
Popáleniny , radiační dermatitis


Rp.

Dexpanthenoli 5,0
Glyceroli 85% 10,0
Alcoholis cetylstearylici 6,0
Glyceroli monostearatis 45–55 5,5
Polysorbati 80 2,0
Dimeticoni 2,0
Paraffini perliquidi 20,0
Aquae purificatae ad 100,0
M. f. crm
D. S. 1–3× denně nanášet na postižená místa.

Oleokrém
Rp.

Dexpanthenoli 5,0
Amygdalae olei raffin. 7,0
Aquae purificatae 30,0
Lanae alcohol. ung. 58,0
M. f. ung
D. S. Nanášet 1–3x denně

Suchá kůže

Rp.

Dexpanthenoli 
Ureae aa 5,0
Acidi lactici 1,0
Natrii lactatis sol. 50% 4,0
Glyceroli 85% 2,0
Dimeticoni 6,0
Aquae purificatae 14,0
Cutilan ad 100,0
M. f. crm
D. S. Potírat několikrát denně.

zdroj

Fytoterapie

Aloe vera
Čubet  benedykt Cnicus benedictus L.
Kostival lékařský  Symphytum officinale L
Kurkuma
Meduňka lékařská   Melissa officinalis L
Pohanka obecná  Fagopyrum esculentum
Rakytník řešetlákový Hippophae rhamnoides
Třapatka nachová Echinacea purpurea
Šalvěj lékařská  Salvia officinalis L. 

Bolest



Doporučené postupy




Adultní tumor z buněk granulozy




Ve zkratce

  • nonepieteliální
  • hormonální sekrece - nejčastěji estrogeny, vzácněji androgeny
  • max.výskyt kolem 60-ti let, jednostranně
  • u 1/4 pacientek hyperplazie endometria až adenoca  (sekrece estrogenů)
  • klinika - UZ cystické  pánevní rezistence v peri a postmenopauzálním věku
  • 50% produkce  protein S100-B
  • nádory do 5 cm stadia IA lze při příznivých histopatologických kriteriích ponechat pouze na dispenzarizaci - dispenzarizace doživotní - možnost  recidivy v dlouholetém odstupu
  • prognostické faktory - kompletní operační výkon,nepřítomnost ruptury, velikost nádoru, jaderné atypie 
  • jinak chemoth - DDP, ADB , nebo BEP
  • prognóza příznivá



Články






Odkazy

Targeted Melanoma Therapy May Change Treatment Landscape: Introduction

Targeted Melanoma Therapy May Change Treatment Landscape: Introduction

Comparative Effectiveness of Prostate Cancer Treatments: Abstract and Introduction

Comparative Effectiveness of Prostate Cancer Treatments: Abstract and Introduction

Roche appeals FDA decision on Avastin - Cancer Network

Roche appeals FDA decision on Avastin - Cancer Network

...European Medicines Agency has already confirmed that the benefits of Avastin in combination with paclitaxel outweigh the risks and considers this a viable treatment option in women with metastatic breast cancer.,,,

NECHÁTE SVÉ DCERY OČKOVAT ? ...!!!!!!! | PŘÍTOMNOST * ANABEA

NECHÁTE SVÉ DCERY OČKOVAT ? ...!!!!!!! | PŘÍTOMNOST * ANABEA

Odkazy





New Target, Drug Potential Found for Colon Cancer

New Target, Drug Potential Found for Colon Cancer

In a study published online January 31st in the Journal of the National Cancer Institute, researchers from the Institute of Cancer Research (ICR) found that Sprycel, known generically as dasatinib and already used in other cancers, reduced bowel cancer cell growth in the lab by blocking the effects of an enzyme called lysyl oxidase, or LOX.

Calcium-Magnesium Combo Eases Oxaliplatin Sensory Effects

Calcium-Magnesium Combo Eases Oxaliplatin Sensory Effects

...The original plan had been to enroll 300 patients. But when only a third of that number had been randomized, unsubstantiated data from a separate trial testing FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for colon cancer suggested that giving magnesium and calcium reduced the effectiveness of the treatment. Later, an independent review of that other trial eventually showed that in fact the magnesium/calcium group had a higher tumor response rate, but by then the current study had been closed.

The report by Dr. Loprinzi and colleagues includes data on 102 colon cancer patients on FOLFOX who received 1g calcium gluconate plus 1g magnesium sulfate pre- and post-oxaliplatin, or placebo. Data cutoff was done after four months and one week....

Dog Sniffing Out Cancer May Lead to Early Detection Test

,newsDog Sniffing Out Cancer May Lead to Early Detection Test

Ipilimumab: A Promising Immunotherapy for Melanoma - Cancer Network

Ipilimumab: A Promising Immunotherapy for Melanoma - Cancer Network


Potential New Biomarker Can Predict Cancer Metastasis - OncologySTAT

Potential New Biomarker Can Predict Cancer Metastasis - OncologySTAT


Analysis: New Mammography Guidelines Will Cost Lives - OncologySTAT

Analysis: New Mammography Guidelines Will Cost Lives - OncologySTAT

...Prior to that time, the USPSTF - and other organizations - recommended screening mammography every 1-2 years for women beginning at age 40. The ACS recommends annual screening mammography starting at age 40....

Molecular Markers May Improve Selection of Patients With Pancreatic Cancer for Surgery - OncologySTAT

Molecular Markers May Improve Selection of Patients With Pancreatic Cancer for Surgery - OncologySTAT


...in the cohort of 372 patients who underwent surgical resection for pancreatic cancer, the markers S100A2 and S100A4, which are associated with more aggressive tumor behavior, predicted worse survival after surgery.
Median survival was almost three times longer when a tumor was immunohistochemically negative for both markers, compared with positive for S100A2 (34.3 vs. 11.9 months). A third group of patients having tumors positive only for S100A4 had intermediate survival (15.6 months)....

ERCC1 Expression Predicts Treatment Outcome in Esophageal Adenocarcinoma - OncologySTAT

ERCC1 Expression Predicts Treatment Outcome in Esophageal Adenocarcinoma - OncologySTAT

...Pretreatment expression of ERCC1 in localized esophageal and gastroesophageal adenocarcinomas is a marker for outcomes among patients given trimodality therapy that includes oxaliplatin-based chemoradiation, investigators reported from a prospective study.

Fully 58% of the 55 patients studied from the Southwest Oncology Group (SWOG) S0356 trial had tumors expressing a high level of mRNA for ERCC1, a key gene in the repair of platinum- and radiation-induced DNA damage.

Adding Bevacizumab to Chemo Raises Treatment-Related Mortality - OncologySTAT

Adding Bevacizumab to Chemo Raises Treatment-Related Mortality - OncologySTAT

...Treatment with taxanes and platinum agents appeared to raise the risk of fatal events associated with bevacizumab. This may reflect an interaction between these classes of drugs and bevacizumab...

FDA Warns of Possible Link Between Breast Implants and Rare Cancer - OncologySTAT

FDA Warns of Possible Link Between Breast Implants and Rare Cancer - OncologySTAT

The Food and Drug Administration is asking health care professionals to report any confirmed cases of anaplastic large cell lymphoma (ALCL) in women with silicone gel- or saline-filled breast implants, citing concerns about a possible association.

The Oncology Report Guide to New Oncology Drugs and Indications Approved in 2010 - OncologySTAT

The Oncology Report Guide to New Oncology Drugs and Indications Approved in 2010 - OncologySTAT

Translate

Antitrombotika dnes

Antitrombotika dnes | proLékaře.cz : Antitrombotika dnes | proLékaře.cz